United States Anti-Infective Drugs Market Report 2016

December 2016 | 107 pages | ID: UDB7B4716E0EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Anti-Infective Drugs

Revenue, means the sales value of Anti-Infective Drugs

This report studies sales (consumption) of Anti-Infective Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• GlaxoSmithKline
• Merck
• Pfizer
• Novartis AG
• Gilead Sciences
• Abbott
• Wyeth
• Sanofi-Aventis
• Bristol-Myers Squibb
• Johnson
• Roche Pharma AG
• Nanosphere
• NanoViricides
• Novabay Pharmaceuticals
• Obetech
• Optimer Pharmaceuticals
• Basilea Pharmaceutica AG
• Daiichi Sankyo
• MerLion Pharma
• Theravance

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Antibiotic
• Antiviral
• Antifungal
• Others

Split by applications, this report focuses on sales, market share and growth rate of Anti-Infective Drugs in each application, can be divided into

• Hospital use
• Clinic
• Household
• Others

Contents

United States Anti-Infective Drugs Market Report 2016

1 ANTI-INFECTIVE DRUGS OVERVIEW

1.1 Product Overview and Scope of Anti-Infective Drugs
1.2 Classification of Anti-Infective Drugs
  1.2.1 Antibiotic
  1.2.2 Antiviral
  1.2.3 Antifungal
  1.2.4 Others
1.3 Application of Anti-Infective Drugs
  1.3.1 Hospital use
  1.3.2 Clinic
  1.3.3 Household
  1.3.4 Others
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Anti-Infective Drugs (2011-2021)
  1.4.1 United States Anti-Infective Drugs Sales and Growth Rate (2011-2021)
  1.4.2 United States Anti-Infective Drugs Revenue and Growth Rate (2011-2021)

2 UNITED STATES ANTI-INFECTIVE DRUGS COMPETITION BY MANUFACTURERS

2.1 United States Anti-Infective Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Anti-Infective Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Anti-Infective Drugs Average Price by Manufactures (2015 and 2016)
2.4 Anti-Infective Drugs Market Competitive Situation and Trends
  2.4.1 Anti-Infective Drugs Market Concentration Rate
  2.4.2 Anti-Infective Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES ANTI-INFECTIVE DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Anti-Infective Drugs Sales and Market Share by Type (2011-2016)
3.2 United States Anti-Infective Drugs Revenue and Market Share by Type (2011-2016)
3.3 United States Anti-Infective Drugs Price by Type (2011-2016)
3.4 United States Anti-Infective Drugs Sales Growth Rate by Type (2011-2016)

4 UNITED STATES ANTI-INFECTIVE DRUGS SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Anti-Infective Drugs Sales and Market Share by Application (2011-2016)
4.2 United States Anti-Infective Drugs Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES ANTI-INFECTIVE DRUGS MANUFACTURERS PROFILES/ANALYSIS

5.1 GlaxoSmithKline
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Anti-Infective Drugs Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 GlaxoSmithKline Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Merck
  5.2.2 Anti-Infective Drugs Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Merck Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Pfizer
  5.3.2 Anti-Infective Drugs Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Pfizer Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Novartis AG
  5.4.2 Anti-Infective Drugs Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Novartis AG Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Gilead Sciences
  5.5.2 Anti-Infective Drugs Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Gilead Sciences Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Abbott
  5.6.2 Anti-Infective Drugs Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Abbott Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Wyeth
  5.7.2 Anti-Infective Drugs Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Wyeth Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Sanofi-Aventis
  5.8.2 Anti-Infective Drugs Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Sanofi-Aventis Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Bristol-Myers Squibb
  5.9.2 Anti-Infective Drugs Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Bristol-Myers Squibb Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Johnson
  5.10.2 Anti-Infective Drugs Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Johnson Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Roche Pharma AG
5.12 Nanosphere
5.13 NanoViricides
5.14 Novabay Pharmaceuticals
5.15 Obetech
5.16 Optimer Pharmaceuticals
5.17 Basilea Pharmaceutica AG
5.18 Daiichi Sankyo
5.19 MerLion Pharma
5.20 Theravance

6 ANTI-INFECTIVE DRUGS MANUFACTURING COST ANALYSIS

6.1 Anti-Infective Drugs Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Anti-Infective Drugs

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Anti-Infective Drugs Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Anti-Infective Drugs Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES ANTI-INFECTIVE DRUGS MARKET FORECAST (2016-2021)

10.1 United States Anti-Infective Drugs Sales, Revenue Forecast (2016-2021)
10.2 United States Anti-Infective Drugs Sales Forecast by Type (2016-2021)
10.3 United States Anti-Infective Drugs Sales Forecast by Application (2016-2021)
10.4 Anti-Infective Drugs Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Anti-Infective Drugs
Table Classification of Anti-Infective Drugs
Figure United States Sales Market Share of Anti-Infective Drugs by Type in 2015
Figure Antibiotic Picture
Figure Antiviral Picture
Figure Antifungal Picture
Figure Others Picture
Table Application of Anti-Infective Drugs
Figure United States Sales Market Share of Anti-Infective Drugs by Application in 2015
Figure Hospital use Examples
Figure Clinic Examples
Figure Household Examples
Figure Others Examples
Figure United States Anti-Infective Drugs Sales and Growth Rate (2011-2021)
Figure United States Anti-Infective Drugs Revenue and Growth Rate (2011-2021)
Table United States Anti-Infective Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Anti-Infective Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Anti-Infective Drugs Sales Share by Manufacturers
Figure 2016 Anti-Infective Drugs Sales Share by Manufacturers
Table United States Anti-Infective Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Anti-Infective Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Anti-Infective Drugs Revenue Share by Manufacturers
Table 2016 United States Anti-Infective Drugs Revenue Share by Manufacturers
Table United States Market Anti-Infective Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Anti-Infective Drugs Average Price of Key Manufacturers in 2015
Figure Anti-Infective Drugs Market Share of Top 3 Manufacturers
Figure Anti-Infective Drugs Market Share of Top 5 Manufacturers
Table United States Anti-Infective Drugs Sales by Type (2011-2016)
Table United States Anti-Infective Drugs Sales Share by Type (2011-2016)
Figure United States Anti-Infective Drugs Sales Market Share by Type in 2015
Table United States Anti-Infective Drugs Revenue and Market Share by Type (2011-2016)
Table United States Anti-Infective Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Anti-Infective Drugs by Type (2011-2016)
Table United States Anti-Infective Drugs Price by Type (2011-2016)
Figure United States Anti-Infective Drugs Sales Growth Rate by Type (2011-2016)
Table United States Anti-Infective Drugs Sales by Application (2011-2016)
Table United States Anti-Infective Drugs Sales Market Share by Application (2011-2016)
Figure United States Anti-Infective Drugs Sales Market Share by Application in 2015
Table United States Anti-Infective Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Anti-Infective Drugs Sales Growth Rate by Application (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Anti-Infective Drugs Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Anti-Infective Drugs Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Anti-Infective Drugs Sales Market Share (2011-2016)
Table Novartis AG Basic Information List
Table Novartis AG Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis AG Anti-Infective Drugs Sales Market Share (2011-2016)
Table Gilead Sciences Basic Information List
Table Gilead Sciences Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Gilead Sciences Anti-Infective Drugs Sales Market Share (2011-2016)
Table Abbott Basic Information List
Table Abbott Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott Anti-Infective Drugs Sales Market Share (2011-2016)
Table Wyeth Basic Information List
Table Wyeth Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Wyeth Anti-Infective Drugs Sales Market Share (2011-2016)
Table Sanofi-Aventis Basic Information List
Table Sanofi-Aventis Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi-Aventis Anti-Infective Drugs Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Anti-Infective Drugs Sales Market Share (2011-2016)
Table Johnson Basic Information List
Table Johnson Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson Anti-Infective Drugs Sales Market Share (2011-2016)
Table Roche Pharma AG Basic Information List
Table Roche Pharma AG Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Pharma AG Anti-Infective Drugs Sales Market Share (2011-2016)
Table Nanosphere Basic Information List
Table Nanosphere Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Nanosphere Anti-Infective Drugs Sales Market Share (2011-2016)
Table NanoViricides Basic Information List
Table NanoViricides Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table NanoViricides Anti-Infective Drugs Sales Market Share (2011-2016)
Table Novabay Pharmaceuticals Basic Information List
Table Novabay Pharmaceuticals Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novabay Pharmaceuticals Anti-Infective Drugs Sales Market Share (2011-2016)
Table Obetech Basic Information List
Table Obetech Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Obetech Anti-Infective Drugs Sales Market Share (2011-2016)
Table Optimer Pharmaceuticals Basic Information List
Table Optimer Pharmaceuticals Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Optimer Pharmaceuticals Anti-Infective Drugs Sales Market Share (2011-2016)
Table Basilea Pharmaceutica AG Basic Information List
Table Basilea Pharmaceutica AG Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Basilea Pharmaceutica AG Anti-Infective Drugs Sales Market Share (2011-2016)
Table Daiichi Sankyo Basic Information List
Table Daiichi Sankyo Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Daiichi Sankyo Anti-Infective Drugs Sales Market Share (2011-2016)
Table MerLion Pharma Basic Information List
Table MerLion Pharma Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table MerLion Pharma Anti-Infective Drugs Sales Market Share (2011-2016)
Table Theravance Basic Information List
Table Theravance Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Theravance Anti-Infective Drugs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anti-Infective Drugs
Figure Manufacturing Process Analysis of Anti-Infective Drugs
Figure Anti-Infective Drugs Industrial Chain Analysis
Table Raw Materials Sources of Anti-Infective Drugs Major Manufacturers in 2015
Table Major Buyers of Anti-Infective Drugs
Table Distributors/Traders List
Figure United States Anti-Infective Drugs Production and Growth Rate Forecast (2016-2021)
Figure United States Anti-Infective Drugs Revenue and Growth Rate Forecast (2016-2021)
Table United States Anti-Infective Drugs Production Forecast by Type (2016-2021)
Table United States Anti-Infective Drugs Consumption Forecast by Application (2016-2021)